OLAPLEX HOLDINGS, INC. — fact timeline

Martijn de Regt was appointed as Director at OLAPLEX HOLDINGS, INC..

“In connection with the Merger, effective as of the Effective Time, Amanda Baldwin, John Duffy, Melisa Gill, and Martijn de Regt were appointed as directors of the Company.”

Melisa Gill was appointed as Director at OLAPLEX HOLDINGS, INC..

“In connection with the Merger, effective as of the Effective Time, Amanda Baldwin, John Duffy, Melisa Gill, and Martijn de Regt were appointed as directors of the Company.”

John Duffy was appointed as Director at OLAPLEX HOLDINGS, INC..

“In connection with the Merger, effective as of the Effective Time, Amanda Baldwin, John Duffy, Melisa Gill, and Martijn de Regt were appointed as directors of the Company.”

Amanda Baldwin was appointed as Director at OLAPLEX HOLDINGS, INC..

“In connection with the Merger, effective as of the Effective Time, Amanda Baldwin, John Duffy, Melisa Gill, and Martijn de Regt were appointed as directors of the Company.”

Michael White departed as Director at OLAPLEX HOLDINGS, INC..

“In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.”

Emily White departed as Director at OLAPLEX HOLDINGS, INC..

“In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.”

David Mussafer departed as Director at OLAPLEX HOLDINGS, INC..

“In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.”

Martha Morfitt departed as Director at OLAPLEX HOLDINGS, INC..

“In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.”

Jerome Griffith departed as Director at OLAPLEX HOLDINGS, INC..

“In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.”

Tricia Glynn departed as Director at OLAPLEX HOLDINGS, INC..

“In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.”

Deirdre Findlay departed as Director at OLAPLEX HOLDINGS, INC..

“In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.”

Pamela Edwards departed as Director at OLAPLEX HOLDINGS, INC..

“In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.”

Christine Dagousset departed as Director at OLAPLEX HOLDINGS, INC..

“In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.”

Amanda Baldwin departed as Director at OLAPLEX HOLDINGS, INC..

“In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.”

John P. Bilbrey departed as Director at OLAPLEX HOLDINGS, INC..

“In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.”

OLAPLEX HOLDINGS, INC. reported the first quarter ended March 31, 2026 results: revenue $99.4 million, net income $(5.3) million, EPS $(0.01).

“team for their continued dedication and commitment to our transformation." For the first quarter of 2026 compared to the first quarter of 2025: • Net sal es increased 2.5% to $99.4 million; ◦ By channel: ▪ Specialty Retail decreased 13.3% to $33.4 million; ▪ Professional increased 12.3% to $38.8 million; ▪ Direct-To-Consumer increased 13.8% to $27.2 million; ◦ Net”

OLAPLEX HOLDINGS, INC. entered into Agreement and Plan of Merger with Henkel US Operations Corporation valued at $2.06 per Share (effective 2026-03-26).

“On March 26, 2026, Olaplex Holdings, Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) by and among the Company, Henkel US Operations Corporation, a Delaware corporation (“ Parent ”), and Margot Acquisition Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“ Merger Sub ”), pursuant to which, subject to the satisfaction or waiver of certain conditions and on the terms set forth therein, Merger Sub will merge (the “ Merger ”) with and into the Company, with the Company continuing as the surviving corporation (the “ Surviving Corporation ”) and a wholly owned subsidiary of Parent.”

Paula Zusi resigned as Director at OLAPLEX HOLDINGS, INC..

“Ms. Zusi's term ended with her resignation from the Board, effective as of the conclusion of the Annual Meeting.”

Kenneth F. Egan was appointed as Interim Chief Accounting Officer at OLAPLEX HOLDINGS, INC..

“On April 28, 2025, the Board of Directors of the Company appointed Kenneth F. Egan to resume his role as Interim Chief Accounting Officer of the Company, effective as of such date.”

Stephen J. Bacica resigned as Chief Accounting Officer at OLAPLEX HOLDINGS, INC..

“On April 23, 2025, Stephen J. Bacica resigned from his role as Chief Accounting Officer of Olaplex Holdings, Inc. (the “Company”), effective as of April 24, 2025, to pursue other interests and for personal reasons.”

Kenneth F. Egan departed as Interim Chief Accounting Officer at OLAPLEX HOLDINGS, INC..

“Mr. Bacica succeeds Kenneth F. Egan, who served as Interim Chief Accounting Officer of the Company from November 5, 2024 until March 19, 2025.”

Stephen J. Bacica was appointed as Chief Accounting Officer at OLAPLEX HOLDINGS, INC..

“the Board appointed Stephen J. Bacica as Chief Accounting Officer of the Company, effective as of March 19, 2025.”

Pamela Edwards was elected as Class II Director at OLAPLEX HOLDINGS, INC..

“the Board of Directors (the “Board”) of Olaplex Holdings, Inc. (the “Company”) elected Pamela Edwards to serve as a Class II director of the Board, with a term expiring at the Company’s 2026 Annual Meeting of Stockholders, and appointed Ms. Edwards as a member of the Audit Committee of the Board (the “Audit Committee”), each effective as of March 19, 2025.”

Paul Kosturos departed as Interim Chief Financial Officer at OLAPLEX HOLDINGS, INC..

“Ms. Dunleavy succeeds Paul Kosturos, who served as interim Chief Financial Officer of the Company from May 6, 2024 until Ms. Dunleavy's appointment.”

Catherine Dunleavy was appointed as Chief Operating Officer and Chief Financial Officer at OLAPLEX HOLDINGS, INC..

“On August 13, 2024, the Board of Directors of Olaplex Holdings, Inc. (the "Company") appointed Catherine Dunleavy, age 55, as Chief Operating Officer and Chief Financial Officer of the Company, effective immediately”

Catherine Dunleavy was appointed as Chief Operating Officer and Chief Financial Officer at OLAPLEX HOLDINGS, INC..

“On July 11, 2024, Olaplex Holdings, Inc. (the “Company”) announced that the Company intends to appoint Catherine Dunleavy, age 55, as Chief Operating Officer (“COO”) and Chief Financial Officer (“CFO”) of the Company, effective as of August 13, 2024.”

Paul Kosturos was appointed as interim Chief Financial Officer at OLAPLEX HOLDINGS, INC..

“appointed Paul Kosturos as interim Chief Financial Officer of the Company, effective May 6, 2024”

Eric Tiziani resigned as Chief Financial Officer at OLAPLEX HOLDINGS, INC..

“Mr. Kosturos succeeds Eric Tiziani, who resigned from his role as Chief Financial Officer of the Company, effective May 6, 2024”

OLAPLEX HOLDINGS, INC. updated its first quarter ended March 31, 2024 guidance (reaffirmed).

“On May 2, 2024, Olaplex Holdings, Inc. (the “Company”) issued a press release announcing its results of operations for the first quarter ended March 31, 2024.”

OLAPLEX HOLDINGS, INC. reported the first quarter of 2024 results: revenue $92 million to $97 million. Guidance reaffirmed.

“the Company today reaffirmed its previously disclosed guidance for net sales for the first quarter of 2024 in the range of $92 million to $97 million”

Paul Kosturos was appointed as Interim Chief Financial Officer at OLAPLEX HOLDINGS, INC..

“The Company intends to appoint Paul Kosturos as Interim Chief Financial Officer of the Company, effective upon the departure of Mr. Tiziani.”

Eric Tiziani resigned as Chief Financial Officer at OLAPLEX HOLDINGS, INC..

“On April 3, 2024, Eric Tiziani, Chief Financial Officer of the Company, resigned from his role as Chief Financial Officer, effective May 6, 2024.”

OLAPLEX HOLDINGS, INC. reported fourth quarter and fiscal year ended December 31, 2023 results: revenue $111.7 million, net income $14,101, EPS $0.02.

“results for the fourth quarter and fiscal year ended December 31, 2023. For the fourth quarter 2023 compared to the fourth quarter 2022 : • Net sales decreased 14.5% to $111.7 million; ◦ Net sales decreased 27.9% in the United States and decreased 0.7% internationally ◦ By channel: ▪ Professional decreased 22.7% to $42.5 million; ▪ Direct-To-Consumer decreased”

John P. Bilbrey changed role as Executive Chair of the Board at OLAPLEX HOLDINGS, INC..

“Ms. Baldwin succeeds John P. Bilbrey, who served as interim Chief Executive Officer from October 12, 2023 until Ms. Baldwin’s appointment and who remains Executive Chair of the Company’s board of directors (the “Board”).”

Amanda Baldwin was elected as Class III Director at OLAPLEX HOLDINGS, INC..

“In addition, on December 11, 2023, the Board elected Ms. Baldwin to serve as a Class III director of the Board with a term expiring at the Company’s 2024 Annual Meeting of Stockholders, effective immediately.”

Amanda Baldwin was appointed as Chief Executive Officer at OLAPLEX HOLDINGS, INC..

“On December 11, 2023, Olaplex Holdings, Inc. (the “Company”) announced that Amanda Baldwin, age 45, has been appointed as Chief Executive Officer (“CEO”) of the Company, effective immediately”

OLAPLEX HOLDINGS, INC. reported the third quarter ended September 30, 2023 results: revenue $123.6 million, net income $20.4 million, EPS $0.03.

“changes that we believe will position the brand for long-term profitable growth." For the third quarter of 2023 compared to the third quarter of 2022: • Net sales were $123.6 million, down 30.0%; ◦ By channel: ▪ Professional was $48.3 million, down 23.3%; ▪ Specialty Retail was $43.2 million, down 41.8%; and ▪ Direct-To-Consumer was $32.1 million, down 18.2%.”

Amanda Baldwin was appointed as Member of the Board of Directors at OLAPLEX HOLDINGS, INC..

“Subject to her appointment as Chief Executive Officer of the Company, Ms. Baldwin also will be appointed to the Board”

Amanda Baldwin was appointed as Chief Executive Officer at OLAPLEX HOLDINGS, INC..

“Amanda Baldwin, pursuant to which Ms. Baldwin and the Company have agreed that she will join the Company as Chief Executive Officer, effective on a date to be determined between November 27, 2023 and January 8, 2024.”

John P. Bilbrey was appointed as Chief Executive Officer at OLAPLEX HOLDINGS, INC..

“John P. Bilbrey has been appointed as interim Chief Executive Officer of the Company, effective as of such date.”

JuE Wong resigned as Member of the Board of Directors at OLAPLEX HOLDINGS, INC..

“Ms. Wong has resigned from her position as a member of the Company’s board of directors (the “Board”), effective October 12, 2023.”

JuE Wong resigned as President and Chief Executive Officer at OLAPLEX HOLDINGS, INC..

“JuE Wong, who no longer serves as President and Chief Executive Officer, effective as of October 12, 2023.”

OLAPLEX HOLDINGS, INC. updated its fiscal year 2023 guidance (lowered).

“we have updated our assumptions for the remainder of the year and reduced our fiscal 2023 outlook.”

OLAPLEX HOLDINGS, INC. reported the second quarter ended June 30, 2023 results: revenue $109.2 million, net income $6.2 million, EPS $0.01. Guidance reaffirmed.

“backed by science and technology, we remain confident in our long-term opportunities." For the second quarter of 2023 compared to the second quarter of 2022: • Net sales were $109.2 million, down 48.2%; ◦ By channel: ▪ Professional was $40.9 million, down 61.2%; ▪ Direct-To-Consumer was $38.5 million, down 6.4%; and ▪ Specialty Retail was $29.8 million, down 53.7%.”

OLAPLEX HOLDINGS, INC. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-06-22 meeting.

“Proposal 3 – Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, based on the following votes: For Against Abstained 607,800,092 52,281 473,867”

OLAPLEX HOLDINGS, INC. shareholders approved Advisory Vote on the Frequency of Future Advisory Votes on Named Executive Officer Compensation at the 2023-06-22 meeting.

“Proposal 2 – Advisory Vote on the Frequency of Future Advisory Votes on Named Executive Officer Compensation The stockholders voted on a non-binding advisory basis on the frequency of future non-binding advisory votes on the compensation of the Company’s named executive officers (“Say-on-Frequency”) as follows: 1 Year 2 Years 3 Years Abstained Broker Non-Votes 602,320,947 354,108 706,571 156,345 4,788,269”

OLAPLEX HOLDINGS, INC. shareholders approved Election of Class II Directors at the 2023-06-22 meeting.

“Proposal 1 – Election of Directors Each of the four nominees listed below were elected as Class II directors at the Annual Meeting to serve on the Company’s Board of Directors (the "Board") for a term of three years expiring at the Company’s 2026 Annual Meeting of Stockholders, based on the following votes: For Withheld Broker Non-Votes Janet Gurwitch 575,798,015 27,739,956 4,788,269 Martha Morfitt 602,490,616 1,047,355 4,788,269 David Mussafer 581,261,746 22,276,225 4,788,269 Emily White 582,461,761 21,076,210 4,788,269”

OLAPLEX HOLDINGS, INC. amended Amendment with Cosway Company Inc. ("Cosway") (effective 2023-06-28).

“On June 28, 2023, Olaplex, Inc. (“Olaplex”) and Cosway Company Inc. (“Cosway”) entered into an amendment (the “Amendment”) to the Letter Agreement, dated February 22, 2023, between Olaplex and Cosway (the “Letter Agreement”), to further extend the expiration date of the Manufacturing Services Agreement, dated January 1, 2020, by and between Olaplex and Cosway, to August 15, 2023 to allow sufficient time to facilitate the negotiation of a new agreement.”

OLAPLEX HOLDINGS, INC. reported first quarter ended March 31, 2023 results: revenue $113.8 million, EPS $0.03.

“consistent and sustained sales growth at continued top-tier profitability in the future." For the first quarter of 2023 compared to the first quarter of 2022: • Net sales were $113.8 million, down 38.9%; ◦ By channel: ▪ Professional was $48.4 million, down 37.2%; ▪ Specialty Retail was $34.9 million, down 45.8%; ▪ Direct-To-Consumer was $30.5 million, down 31.9%; ◦”

OLAPLEX HOLDINGS, INC. reported Q4 2022 results: revenue $ 130,721, net income $ 33,633, EPS $ 0.05.

“Fourth Quarter 2022 Highlights (Dollars in $000’s, except per share data) Q4 2022 Q4 2021 % Change Net Sales $ 130,721 GL $ 166,498 (21.5)% Gross Profit $ 92,090 $ 132,213 (30.3)% Gross Profit Margin 70.4 % 79.4 % Adjusted Gross Profit $ 94,735 $ 133,803 (29.2)% Adjusted Gross Profit Margin 72.5 % 80.4 % SG&A $ 34,645 $ 23,555 47.1% Adjusted SG&A $ 28,836 $ 22,605 27.6% Net Income $ 33,633 $ 69,311 (51.5)% Adjusted Net Income $ 48,325 $ 71,393 (32.3)% Adjusted EBITDA $ 67,626 $ 110,678 (38.9)% Adjusted EBITDA Margin 51.7 % 66.5 % Diluted EPS $ 0.05 $ 0.10 (50.0)% Adjusted Diluted EPS $ 0.07 $ 0.10 (30.0)% Weighted Average Diluted Shares Outstanding 686,036,091 692,863,933”